Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B

被引:24
作者
Chen, L
He, M
Sibille, E
Thompson, A
Sarnyai, Z
Baker, H
Shippenberg, T
Toth, M
机构
[1] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA
[2] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA
[3] Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Burke Med Res Inst, White Plains, NY USA
[5] NIDA, Integrat Neurosci Unit, Behav Neurosci Branch, Intramural Res Program, Baltimore, MD USA
关键词
monoamine oxidase B; dopamine receptor; tyrosine hydroxylase; knockout mice; in vivo microdialysis;
D O I
10.1046/j.1471-4159.1999.0730647.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidase (MAO) B is considered a key enzyme in dopamine metabolism. The present studies, conducted in MAO B knockout mice, show that lack of MAO B does not alter extracellular levels of dopamine in striatum. Similarly, the synthesis, storage, uptake, and release of dopamine are also unaltered. However, autoradiography revealed a significant up-regulation of the D2-like dopamine receptors in the striatum of MAO B knockout mice. Mutant mice also exhibit a functional supersensitivity of D1-dopamine receptors in the nucleus accumbens. Thus, the agonist SKF 38,393-induced c-Fos immunoreactivity was significantly increased in knockout mice as compared with wild-type controls. In view of the apparently normal basal dopamine dynamics observed in MAO B knockout mice, we hypothesize that a dopamine-independent mechanism underlies adaptations in dopamine receptor function that occur as a consequence of MAO B depletion. Finally, these findings suggest that chronic administration of MAO inhibitors, as occurs in the treatment of Parkinson's disease and depression, may be associated with an increased responsiveness of CNS neurons to dopamine receptor ligands.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 48 条
[1]   FUNCTIONAL-HETEROGENEITY OF THE CAUDATE-PUTAMEN AS REVEALED BY C-FOS INDUCTION IN RESPONSE TO D1 RECEPTOR ACTIVATION [J].
ARNAULD, E ;
ARSAUT, J ;
DEMOTESMAINARD, J .
MOLECULAR BRAIN RESEARCH, 1993, 18 (04) :339-342
[2]  
BOJA JW, 1995, MOL PHARMACOL, V47, P779
[3]   DIFFERENTIAL INHIBITION OF SYNAPTOSOMAL ACCUMULATION OF [H-3] MONOAMINES BY COCAINE, TROPACOCAINE AND AMPHETAMINE IN 4 INBRED STRAINS OF MICE [J].
BOSY, TZ ;
RUTH, JA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (01) :165-172
[4]   In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism [J].
Brannan, T ;
Prikhojan, A ;
MartinezTica, J ;
Yahr, MD .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1995, 10 (2-3) :79-89
[5]   STEADY-STATE THEORY FOR QUANTITATIVE MICRODIALYSIS OF SOLUTES AND WATER INVIVO AND INVITRO [J].
BUNGAY, PM ;
MORRISON, PF ;
DEDRICK, RL .
LIFE SCIENCES, 1990, 46 (02) :105-119
[6]   EFFECTS OF SELECTIVE MONOAMINE-OXIDASE INHIBITORS ON THE INVIVO RELEASE AND METABOLISM OF DOPAMINE IN THE RAT STRIATUM [J].
BUTCHER, SP ;
FAIRBROTHER, IS ;
KELLY, JS ;
ARBUTHNOTT, GW .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) :981-988
[7]  
DURDEN DA, 1980, J NEUROCHEM, V34, P1725
[8]  
ELMESTIKAWY S, 1986, J NEUROCHEM, V47, P1425
[9]   PHARMACOGENETICS OF COCAINE .2. MESOCORTICOLIMBIC AND STRIATAL DOPAMINE AND COCAINE RECEPTORS IN C57BL AND DBA MICE [J].
ERWIN, VG ;
WOMER, DE ;
CAMPBELL, AD ;
JONES, BC .
PHARMACOGENETICS, 1993, 3 (04) :189-196
[10]  
Finberg JPM, 1996, J NEURAL TRANSM-SUPP, P95